Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Results from Hemato-Oncology Latin America Observational Registry (HOLA) Providing Real World Outcomes for the Treatment of Patients with CLL

Carlos Chiattone, MD PhD, David Gomez-Almaguer, MD, Carolina Pavlovsky, MD, Elena Tuna-Aguilar, MD, Ana Lisa Basquiera, MD, Luis Palmer, MD, Danielle Leao Cordeiro De Farias, MD MSc, Sergio Schusterschitz, MD, Kenny Mauricio Galvez, Álvaro Gómez, MD, Telma Santos, MD PhD, Odin De La Mora Estrada, MD

Blood (2016) 128 (22): 5578.

https://doi.org/10.1182/blood.V128.22.5578.5578

Published: 2016

Journal Articles

Clinical Characteristics and Outcome of 104 Patients with Gastric Diffuse B-Cell Non-Hodgkin Lymphoma (DLBCL) a Multicenter Study

Marcia T Delamain, MD, Eliana Cristina Martins Miranda, PhD, Maria Gomes da Silva, MDPhD, Joana Desterro, MD, Merli Francesco, MD, Carlos Chiattone, MD PhD, Stefano Luminari, MD, Katia BB Pagnano, Carmino Antonio De Souza, MD PhD, Massimo Federico

Blood (2015) 126 (23): 5032.

https://doi.org/10.1182/blood.V126.23.5032.5032

Published: 2015

Journal Articles

The Oral Mtor Inhibitor Everolimus in Relapsed and Refractory Hodgkin Lymphoma- Compassionate Use in 8 Centers in Brazil

Talita Silveira Da Rocha, MD, Sergio Costa Fortier, MD, Nelson Siqueira de Castro, MD, Marcia T Delamain, MD, José Salvador Oliveira, PhD, Guilherme Perini, MD, Valeria Buccheri, PhD, Rafael Dezen Gaiolla, MD, Laura Fogliato, PhD, Andressa Laranja, Maeva Pinto, MD, Carlos Chiattone, MD PhD

Blood (2015) 126 (23): 5107.

https://doi.org/10.1182/blood.V126.23.5107.5107

Published: 2015

Journal Articles

Prevalence of Oligoclonal Bands in Multiple Myeloma Patients Who Achieved Better Results Than Very Good Partial Response after Treatment with Standard or High Doses Chemotherapy-Final Analysis

Luiza soares Vieira, MD, Edvan de queiroz Crusoe, MD MsC, Manuella de S. Sampaio Almeida, MD PhD, Lais Sousa, MD, ana Lucia Perez, MD, Priscilla Cury, MD, Marina Rossato, MD, Fabiana Higashi, MD, ana Luiza Dias, MD, anna Carolina Castro, MD, Carlos Chiattone, MD PhD, Vania T M Hungria, MDPhD

Blood (2015) 126 (23): 4210.

https://doi.org/10.1182/blood.V126.23.4210.4210

Published: 2015

Journal Articles

IgA Levels Can Predict Survival in CLL Patients: A Retrospective Analysis of 183 Cases in a Brazilian Cohort

Sérgio Costa Fortier, MD, Natália Zing, MD, Fabio Lima da Silva, MD, Viviane Mayumi Endo, Talita Silveira Da Rocha, MD, Bárbara Tannus, MD, Maeva Pinto, MD, Carlos Chiattone, MD PhD

Blood (2015) 126 (23): 5284.

https://doi.org/10.1182/blood.V126.23.5284.5284

Published: 2015

Journal Articles

Analysis of Calcium Profile and Bone Mineral Density in Patients with Sickle Cell Disease

Lucila Macedo Gonçalves, Rodolfo Cancado, Tarissa Beatrice Zanata Petry, Murilo Rezende Melo, João Eduardo Salles, Nilza Maria Scalissi, Carlos Chiattone, MD, PhD

Blood (2010) 116 (21): 4810.

https://doi.org/10.1182/blood.V116.21.4810.4810

Published: 2010

Journal Articles

Effect of Genetic Polymorphisms Related to Folate and Homocysteine Metabolism In the Etiology of Recurrent Miscarriages

Elvira Maria Guerra-Shinohara, PhD, Kelma Cordeiro da Silva Giusti, Nathalia Sierra Monteiro, Robson José Lazaro, Fernanda Midori Seino, Carolina Tosin Bueno, Mário Henrique Burlacchini Carvalho, MD, PhD, Antônio Amorim Filho, MD, Carlos Chiattone, MD, PhD, Marcelo Zugaib, MD, PhD

Blood (2010) 116 (21): 5136.

https://doi.org/10.1182/blood.V116.21.5136.5136

Published: 2010

Journal Articles

Global Sequencing for the Molecular Background of Hereditary Hemochomatosis In Brazilian Patients

Elvira Maria Guerra-Shinohara, PhD, Paulo Caleb Santos, Rodolfo Cancado, MD, PhD, Alexandre Pereira, MD, PhD, Isolmar Schettert, MD, Renata Soares, Rosario D C Hirata, PhD, Mario H Hirata, PhD, Regina Pagliusi, Maria Stella Figueiredo, MD, PhD, José Eduardo Krieger, MD, PhD, Carlos Chiattone, MD, PhD

Blood (2010) 116 (21): 5146.

https://doi.org/10.1182/blood.V116.21.5146.5146

Published: 2010

Journal Articles

Deferasirox for the Treatment of Transfusional Iron Overload In Sickle Cell Anemia: a 2-Yr Prospective Study

Rodolfo Cancado, Maria Cristina Olivato, Paula Bruniera, Murilo Rezende Melo, Carlos Chiattone, MD, PhD

Blood (2010) 116 (21): 5148.

https://doi.org/10.1182/blood.V116.21.5148.5148

Published: 2010

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation in T-Cell Non-Hodgkin Lymphoma.

Frederico L. Dulley, MD, PhD, Daniel Sturaro, Pharmacist, Milton A. Ruiz, MD, PhD, Carlos Chiattone, MD, PhD, Rosaura Saboya, MD, PhD, Jose C. Barros, MD, Jose P. Sarmento-Neto, MD, Jose U. Amigo-Filho, MD, Lilian Piron-Ruiz, MD, Juliana Pereira, MD, Dalton A.F. Chamone, MD, PhD

Blood (2006) 108 (11): 5379.

https://doi.org/10.1182/blood.V108.11.5379.5379

Published: 2006

Journal Articles

Nasal/Nasal Type NK/T-Cell Lymphoma: A Brazilian Experience of 40 Cases.

Carlos Chiattone, MD, PhD, Roberto P. Paes, MD,PhD, Lidio Granato, MD,PhD, Vania T.M. Hungria, MD,PhD, Fausto F. Alonso, MD,PhD, Peter G. Isaacson, MBChB,DM,FRCPath

Blood (2006) 108 (11): 4627.

https://doi.org/10.1182/blood.V108.11.4627.4627

Published: 2006

Journal Articles

BCL2 Expression Is a Prognostic Marker for the Activated B-Cell-Like Type of Diffuse Large B-Cell Lymphoma.

Carlos Chiattone, MD, PhD, Marineide P. Carvalho, MD, Roberto P. Paes, MD,PhD, Karina C.B. Ribeiro, MD,PhD, Fernando Soares, MD,PhD

Blood (2006) 108 (11): 4635.

https://doi.org/10.1182/blood.V108.11.4635.4635

Published: 2006

Journal Articles

Immunohistochemical Expression Pattern of Germinal Center and Non-Germinal Center Markers Correlates with Prognosis in Diffuse Large B-Cell Lymphoma.

Carlos Chiattone, MD, PhD, Marineide P. Carvalho, MD, Roberto P. Paes, MD,PhD, Karina C.B. Ribeiro, MD,PhD, Fernando Soares, MD,PhD

Blood (2006) 108 (11): 4636.

https://doi.org/10.1182/blood.V108.11.4636.4636

Published: 2006

Journal Articles

Observacional Study for Evaluation of Quality of Life in Patients with Chronic Myeloid Leukemia (CML) in Use of Gleevec® (Imatinib Mesilate).

Ricardo Pasquini, MD, PhD, Nelma C. Clementino, MD, PhD, Maria A. Zanichelli, MD, PhD, Alexandre Nonino, MD, Acy T. Quixadá, MD, Carlos Chiattone, MD, PhD, Ana D. Freire, MD, Libia P. Villela, MD, Iê R. Bentes, MD, Waldir V. Pereira, MD, PhD, Lucia Silla, MD, PhD, Iara Zaparoli, MD, Márcia M. Bisterço, MD, Cármino A. De Souza, MD, PhD, Vergílio Colturato, MD, Íris Massaut, MD, Eduardo M. Rego, MD, PhD, Claudia Vasconcelos, MD.

Blood (2004) 104 (11): 2932.

https://doi.org/10.1182/blood.V104.11.2932.2932

Published: 2004

NARROW

Results from Hemato-Oncology Latin America Observational Registry (HOLA) Providing Real World Outcomes for the Treatment of Patients with CLL

Clinical Characteristics and Outcome of 104 Patients with Gastric Diffuse B-Cell Non-Hodgkin Lymphoma (DLBCL) a Multicenter Study

The Oral Mtor Inhibitor Everolimus in Relapsed and Refractory Hodgkin Lymphoma- Compassionate Use in 8 Centers in Brazil

Prevalence of Oligoclonal Bands in Multiple Myeloma Patients Who Achieved Better Results Than Very Good Partial Response after Treatment with Standard or High Doses Chemotherapy-Final Analysis

IgA Levels Can Predict Survival in CLL Patients: A Retrospective Analysis of 183 Cases in a Brazilian Cohort

Analysis of Calcium Profile and Bone Mineral Density in Patients with Sickle Cell Disease

Effect of Genetic Polymorphisms Related to Folate and Homocysteine Metabolism In the Etiology of Recurrent Miscarriages

Global Sequencing for the Molecular Background of Hereditary Hemochomatosis In Brazilian Patients

Deferasirox for the Treatment of Transfusional Iron Overload In Sickle Cell Anemia: a 2-Yr Prospective Study

Allogeneic Hematopoietic Stem Cell Transplantation in T-Cell Non-Hodgkin Lymphoma.

Nasal/Nasal Type NK/T-Cell Lymphoma: A Brazilian Experience of 40 Cases.

BCL2 Expression Is a Prognostic Marker for the Activated B-Cell-Like Type of Diffuse Large B-Cell Lymphoma.

Immunohistochemical Expression Pattern of Germinal Center and Non-Germinal Center Markers Correlates with Prognosis in Diffuse Large B-Cell Lymphoma.

Observacional Study for Evaluation of Quality of Life in Patients with Chronic Myeloid Leukemia (CML) in Use of Gleevec® (Imatinib Mesilate).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only